Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1
about
Genome-wide prediction and validation of peptides that bind human prosurvival Bcl-2 proteinsMathematical modeling identifies inhibitors of apoptosis as mediators of positive feedback and bistabilityApoptosis repressor with caspase recruitment domain protects against cell death by interfering with Bax activationMolecular cloning of ILP-2, a novel member of the inhibitor of apoptosis protein familyA surface groove essential for viral Bcl-2 function during chronic infection in vivo.Apoptosis and autophagy induction as mechanism of cancer prevention by naturally occurring dietary agentsApoptosis: a review of programmed cell deathWhole-genome sequencing in multiplex families with psychoses reveals mutations in the SHANK2 and SMARCA1 genes segregating with illness.GLTSCR2/PICT-1, a putative tumor suppressor gene product, induces the nucleolar targeting of the Kaposi's sarcoma-associated herpesvirus KS-Bcl-2 protein.Pro-apoptotic proteins released from the mitochondria regulate the protein composition and caspase-processing activity of the native Apaf-1/caspase-9 apoptosome complex.Analysis of the composition, assembly kinetics and activity of native Apaf-1 apoptosomes.DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines.A global transcriptional view of apoptosis in human T-cell activation.Molecular cloning and expression of Aven gene in chicken.Post-cytochrome C protection from apoptosis conferred by a MAPK pathway in Xenopus egg extractsCharacterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin.Crosstalk between apoptosis and autophagy: molecular mechanisms and therapeutic strategies in cancer.Regulation of the Apaf-1-caspase-9 apoptosomeApoptosis and its clinical impact.Multiple functions of BCL-2 family proteins.Identification of dAven, a Drosophila melanogaster ortholog of the cell cycle regulator AvenViral versus cellular BCL-2 proteins.Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potential.Viral Bcl-2 Encoded by the Kaposi's Sarcoma-Associated Herpesvirus Is Vital for Virus Reactivation.The kinder side of killer proteases: caspase activation contributes to neuroprotection and CNS remodelingAdult neuron survival strategies--slamming on the brakes.More than one way to go.Strong Components of Epigenetic Memory in Cultured Human Fibroblasts Related to Site of Origin and Donor AgeAn Integrated Bioinformatics and Computational Biology Approach Identifies New BH3-Only Protein CandidatesInternal ribosome entry segment-mediated translation during apoptosis: the role of IRES-trans-acting factors.The Apaf-1-binding protein Aven is cleaved by Cathepsin D to unleash its anti-apoptotic potentialForkhead-box transcription factor 1 affects the apoptosis of natural regulatory T cells by controlling Aven expression.Transcriptome sequencing of malignant pleural mesothelioma tumorsCharacterisation of the anti-apoptotic function of survivin-DeltaEx3 during TNFalpha-mediated cell death.Novel molecular changes induced by Nrg1 hypomorphism and Nrg1-cannabinoid interaction in adolescence: a hippocampal proteomic study in miceGenomic profiling in locally advanced and inflammatory breast cancer and its link to DCE-MRI and overall survival.The discovery of a novel inhibitor of apoptotic protease activating factor-1 (Apaf-1) for ischemic heart: synthesis, activity and target identificationCyclin A2 confers cisplatin resistance to endometrial carcinoma cells via up-regulation of an Akt-binding protein, periplakin.Endogenous elevation of homocysteine induces retinal neuron death in the cystathionine-beta-synthase mutant mouse.Bcr-Abl-mediated protection from apoptosis downstream of mitochondrial cytochrome c release.
P2860
Q21145296-DB627242-B010-49DF-9250-D2CEFA73F0A2Q21563509-8B1040A4-420A-497E-986F-A4DEB6EA2B20Q24314624-D09C5D9B-471D-4EC5-8FA0-FB05A750B570Q24550944-7DB7B9E4-E00E-4A1A-857D-10610B50F06BQ24817200-28FC32BD-ED1F-4E73-9AB4-A82BAA541650Q26866257-59FB73CA-DFB9-46AB-8EBB-9C9E885F333EQ28305845-B67B3693-D02E-4F72-83AD-3BFDCB8B66A9Q30008997-42C78F4A-A8FC-4FBB-B7E4-B1515744046CQ30090237-1DC55F0A-56EC-4920-B38A-5C87868BACF9Q30753875-ECF46CA6-CD88-4637-9450-9B13EAF42F39Q30830747-C53CA801-EE24-4D5B-AC37-B5DCF809B181Q30931932-7D3C3E4C-C829-48EE-ABE7-3D2545B7B7CDQ33378974-5BFF501C-217D-4977-8283-C96782439931Q33793238-6F11937B-938C-4DD4-B856-F3BD7C2AD33FQ33953642-4C9C5F56-C45D-4B39-974F-C94F6169FA13Q34088693-99F15717-2FD8-4A5B-B2E5-9FD0355BA234Q34102626-7AA61ACD-5656-40B9-BF33-9BB3FD7DEFF0Q34129476-34BBD4DB-455A-4B69-A053-83A7899E9FFEQ34214558-D68CF4FC-2C04-4C41-84A7-41F1EF1FDE7BQ34326024-95B0FB51-5497-4083-9904-A9B98E3FDEB5Q35002331-0917054E-70CC-4FFC-A2A9-AA5C73BF7494Q35091480-EC888C04-3FA9-4B75-B7BC-2D0BE94CD941Q35406465-165D0BB0-CF9C-45E5-9420-D790EE18E2C2Q35641410-CEBBA47E-5F0B-453F-9D0D-DFBB347F5091Q35683839-35599146-7376-4027-9EC6-286A704FD2C5Q35868063-16A2270E-ADE3-4E11-A72F-13BDF50750A1Q35908531-A276CBEF-4E83-4041-8C28-6F137F7DF6B9Q35935312-30AFDE59-FEA4-4A2F-975C-6D43ABBFA3BFQ36062566-F62DC076-6074-401C-BA18-CAB683DDE832Q36131048-7E3B7B73-6516-4AC2-8EE1-2BD700067443Q36174027-0E51637D-868A-4A1E-B676-A55855F298DAQ36304690-EA121D68-1FDD-41E2-AE0A-BE37946D9B68Q36491120-333105C8-295F-408D-88EA-CBD64D1640E8Q36609488-82FF7201-DC84-4F19-8D1D-E8F20B3EFE22Q36637155-F30DD7EE-A2F3-4E1C-9AFC-B2D3D7C77F45Q37114252-37CA9C3F-D32D-407C-B446-0808B9093CA1Q37117825-67C696FF-DEA6-4E6F-9BC4-94E0C23A97F6Q37293935-17ACFD24-3C48-4EB4-A031-96754DC9E74BQ37372487-B8762315-C176-4532-AA14-E5AB461B5549Q37622705-8384FE5B-AFDA-492D-ACDF-1D0E9B5BEF6E
P2860
Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1
@ast
Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1
@en
Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1
@en-gb
Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1
@nl
type
label
Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1
@ast
Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1
@en
Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1
@en-gb
Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1
@nl
prefLabel
Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1
@ast
Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1
@en
Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1
@en-gb
Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1
@nl
P2093
P1433
P1476
Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1
@en
P2093
P356
10.1016/S1097-2765(00)00005-8
10.1016/S1097-2765(05)00021-3
P407
P577
2000-07-01T00:00:00Z